These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23372927)

  • 1. New models of pulmonary hypertension based on VEGF receptor blockade-induced endothelial cell apoptosis.
    Nicolls MR; Mizuno S; Taraseviciene-Stewart L; Farkas L; Drake JI; Al Husseini A; Gomez-Arroyo JG; Voelkel NF; Bogaard HJ
    Pulm Circ; 2012 Oct; 2(4):434-42. PubMed ID: 23372927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization.
    Mizuno S; Farkas L; Al Husseini A; Farkas D; Gomez-Arroyo J; Kraskauskas D; Nicolls MR; Cool CD; Bogaard HJ; Voelkel NF
    Am J Respir Cell Mol Biol; 2012 Nov; 47(5):679-87. PubMed ID: 22842496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of antiangiogenic compound SU5416 in a rat model of pulmonary arterial hypertension.
    Sakao S; Tatsumi K
    Respiration; 2011; 81(3):253-61. PubMed ID: 21116108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumonectomy combined with SU5416 induces severe pulmonary hypertension in rats.
    Happé CM; de Raaf MA; Rol N; Schalij I; Vonk-Noordegraaf A; Westerhof N; Voelkel NF; de Man FS; Bogaard HJ
    Am J Physiol Lung Cell Mol Physiol; 2016 Jun; 310(11):L1088-97. PubMed ID: 27036867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of T cells confers increased pulmonary arterial hypertension and vascular remodeling.
    Taraseviciene-Stewart L; Nicolls MR; Kraskauskas D; Scerbavicius R; Burns N; Cool C; Wood K; Parr JE; Boackle SA; Voelkel NF
    Am J Respir Crit Care Med; 2007 Jun; 175(12):1280-9. PubMed ID: 17413127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dominant Role for Regulatory T Cells in Protecting Females Against Pulmonary Hypertension.
    Tamosiuniene R; Manouvakhova O; Mesange P; Saito T; Qian J; Sanyal M; Lin YC; Nguyen LP; Luria A; Tu AB; Sante JM; Rabinovitch M; Fitzgerald DJ; Graham BB; Habtezion A; Voelkel NF; Aurelian L; Nicolls MR
    Circ Res; 2018 Jun; 122(12):1689-1702. PubMed ID: 29545367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension.
    Taraseviciene-Stewart L; Kasahara Y; Alger L; Hirth P; Mc Mahon G; Waltenberger J; Voelkel NF; Tuder RM
    FASEB J; 2001 Feb; 15(2):427-38. PubMed ID: 11156958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel rat model of pulmonary hypertension induced by mono treatment with SU5416.
    Chen Y; Kuang M; Liu S; Hou C; Duan X; Yang K; He W; Liao J; Zheng Q; Zou G; Chen H; Yan H; Chen J; Li Y; Zhou Y; Luo X; Jiang Q; Tang H; Lu W; Wang J
    Hypertens Res; 2020 Aug; 43(8):754-764. PubMed ID: 32472112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of severe angioproliferative pulmonary arterial hypertension and right ventricular hypertrophy by combined phosphodiesterase-5 and endothelin receptor inhibition.
    Cavasin MA; Demos-Davies KM; Schuetze KB; Blakeslee WW; Stratton MS; Tuder RM; McKinsey TA
    J Transl Med; 2014 Nov; 12():314. PubMed ID: 25425003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A bradykinin antagonist and a caspase inhibitor prevent severe pulmonary hypertension in a rat model.
    Taraseviciene-Stewart L; Gera L; Hirth P; Voelkel NF; Tuder RM; Stewart JM
    Can J Physiol Pharmacol; 2002 Apr; 80(4):269-74. PubMed ID: 12025960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like Receptor 3 Is a Therapeutic Target for Pulmonary Hypertension.
    Farkas D; Thompson AAR; Bhagwani AR; Hultman S; Ji H; Kotha N; Farr G; Arnold ND; Braithwaite A; Casbolt H; Cole JE; Sabroe I; Monaco C; Cool CD; Goncharova EA; Lawrie A; Farkas L
    Am J Respir Crit Care Med; 2019 Jan; 199(2):199-210. PubMed ID: 30211629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats.
    Bogaard HJ; Natarajan R; Mizuno S; Abbate A; Chang PJ; Chau VQ; Hoke NN; Kraskauskas D; Kasper M; Salloum FN; Voelkel NF
    Am J Respir Crit Care Med; 2010 Sep; 182(5):652-60. PubMed ID: 20508210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted activation of endothelin-1 exacerbates hypoxia-induced pulmonary hypertension.
    Satwiko MG; Ikeda K; Nakayama K; Yagi K; Hocher B; Hirata K; Emoto N
    Biochem Biophys Res Commun; 2015 Sep; 465(3):356-62. PubMed ID: 26275708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of reactive oxygen species to the pathogenesis of pulmonary arterial hypertension.
    Jernigan NL; Naik JS; Weise-Cross L; Detweiler ND; Herbert LM; Yellowhair TR; Resta TC
    PLoS One; 2017; 12(6):e0180455. PubMed ID: 28666030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SU5416 plus hypoxia but not selective VEGFR2 inhibition with cabozantinib plus hypoxia induces pulmonary hypertension in rats: potential role of BMPR2 signaling.
    Sitapara R; Sugarragchaa C; Zisman LS
    Pulm Circ; 2021; 11(3):20458940211021528. PubMed ID: 34178306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial cell-related autophagic pathways in Sugen/hypoxia-exposed pulmonary arterial hypertensive rats.
    Kato F; Sakao S; Takeuchi T; Suzuki T; Nishimura R; Yasuda T; Tanabe N; Tatsumi K
    Am J Physiol Lung Cell Mol Physiol; 2017 Nov; 313(5):L899-L915. PubMed ID: 28798259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidants for the treatment of patients with severe angioproliferative pulmonary hypertension?
    Voelkel NF; Bogaard HJ; Al Husseini A; Farkas L; Gomez-Arroyo J; Natarajan R
    Antioxid Redox Signal; 2013 May; 18(14):1810-7. PubMed ID: 22870869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolyl-4 Hydroxylase 2 (PHD2) Deficiency in Endothelial Cells and Hematopoietic Cells Induces Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension in Mice and Humans Through Hypoxia-Inducible Factor-2α.
    Dai Z; Li M; Wharton J; Zhu MM; Zhao YY
    Circulation; 2016 Jun; 133(24):2447-58. PubMed ID: 27143681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Janus face of vascular endothelial growth factor: the obligatory survival factor for lung vascular endothelium controls precapillary artery remodeling in severe pulmonary hypertension.
    Voelkel NF; Cool C; Taraceviene-Stewart L; Geraci MW; Yeager M; Bull T; Kasper M; Tuder RM
    Crit Care Med; 2002 May; 30(5 Suppl):S251-6. PubMed ID: 12004244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfated dehydropolymer of caffeic acid: In vitro anti-lung cell death activity and in vivo intervention in emphysema induced by VEGF receptor blockade.
    Truong TM; Li H; Dhapare S; Desai UR; Voelkel NF; Sakagami M
    Pulm Pharmacol Ther; 2017 Aug; 45():181-190. PubMed ID: 28648907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.